Children are the latest test subjects of FluGen’s universal flu vaccine

An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health.

The test began in August, according to a statement last week by the National Institute of Allergy and Infectious Diseases.

Fifty healthy children between the ages of 9 and 17 will be studied at a vaccine and treatment evaluation unit at Saint Louis University, in St. Louis, Missouri, over the next year.